TAK Currently At Short Entry

NYSE:TAK   Takeda Pharmaceutical Company Limited
TAK showing large wick rejection on weekly. Reward/risk here is 3.0 with trade as pictured and entries scattered across the red zone.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.